Crossmark

Glucagon-Like Peptide-1 Receptor Agonists Are Promising for the Treatment of Brain Diseases: an Outlook from the Perspective of Integrative Physiology

Crossref DOI link: https://doi.org/10.1134/S0022093025050023

Published Online: 2025-11-05

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gulyaeva, N. V.
License Information

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-11-05
More Information

Article History

Received: 23 August 2025

Revised: 6 September 2025

Accepted: 15 September 2025

First Online: 5 November 2025

COMPLIANCE WITH ETHICAL STANDARDS

: There are no human or animal studies in this paper.

: The author of this work declares that she has no conflicts of interest.

Document is current

Any future updates will be listed below